Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
Titel:
Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland
Auteur:
Ramasamy, Maheshi N Kelly, Elizabeth J Seegobin, Seth Dargan, Paul I Payne, Ruth Libri, Vincenzo Adam, Matthew Aley, Parvinder K Martinez-Alier, Nuria Church, Alison Jepson, Brett Khan, Mark Matthews, Sam Townsend, G Todd Vekemans, Johan Bibi, Sagida Swanson II, Phillip A Lambe, Teresa Pangalos, Menelas N Villafana, Tonya Pollard, Andrew J Green, Justin A
Verschenen in:
Lancet microbe
Paginering:
Jaargang 4 () nr. 11 pagina's e863-e874
Jaar:
2023
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license